Titre : Acides lévuliniques

Acides lévuliniques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Flow Cytometry
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acides lévuliniques : Questions médicales les plus fréquentes", "headline": "Acides lévuliniques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acides lévuliniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acides lévuliniques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cétoacides", "url": "https://questionsmedicales.fr/mesh/D007651", "about": { "@type": "MedicalCondition", "name": "Cétoacides", "code": { "@type": "MedicalCode", "code": "D007651", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.755" } } }, "about": { "@type": "MedicalCondition", "name": "Acides lévuliniques", "alternateName": "Levulinic Acids", "code": { "@type": "MedicalCode", "code": "D007982", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kyoungseon Min", "url": "https://questionsmedicales.fr/author/Kyoungseon%20Min", "affiliation": { "@type": "Organization", "name": "Gwangju Clean Energy Research Center, Korea Institute of Energy Research (KIER), Gwangju 61003, Republic of Korea. Electronic address: min4605@kier.re.kr." } }, { "@type": "Person", "name": "Zhihao Yu", "url": "https://questionsmedicales.fr/author/Zhihao%20Yu", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } }, { "@type": "Person", "name": "Xuebin Lu", "url": "https://questionsmedicales.fr/author/Xuebin%20Lu", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } }, { "@type": "Person", "name": "Jian Xiong", "url": "https://questionsmedicales.fr/author/Jian%20Xiong", "affiliation": { "@type": "Organization", "name": "Department of Chemistry & Environmental Science, School of Science, Tibet University, Lhasa, 850000, P. R. China." } }, { "@type": "Person", "name": "Na Ji", "url": "https://questionsmedicales.fr/author/Na%20Ji", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Ophthalmic artery flow direction change predicts recurrence of ischemic stroke after carotid stenting: a longitudinal observational study.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36593520", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40001-022-00965-9" } }, { "@type": "ScholarlyArticle", "name": "Near-Infrared Light-Responsive Size-Selective Lateral Flow Chip for Single-Cell Manipulation of Circulating Tumor Cells.", "datePublished": "2022-12-21", "url": "https://questionsmedicales.fr/article/36541430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.analchem.2c03947" } }, { "@type": "ScholarlyArticle", "name": "Trimetallic Au@Pd@Pt nanozyme-enhanced lateral flow immunoassay for the detection of SARS-CoV-2 nucleocapsid protein.", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36468531", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2ay01530g" } }, { "@type": "ScholarlyArticle", "name": "Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36555939", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/jcm11247323" } }, { "@type": "ScholarlyArticle", "name": "Lateralization of cerebral blood flow in the auditory cortex of patients with idiopathic tinnitus and healthy controls: An arterial spin labeling study.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36636575", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fnins.2022.992758" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Cétoacides", "item": "https://questionsmedicales.fr/mesh/D007651" }, { "@type": "ListItem", "position": 5, "name": "Acides lévuliniques", "item": "https://questionsmedicales.fr/mesh/D007982" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acides lévuliniques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acides lévuliniques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acides lévuliniques", "description": "Comment diagnostiquer une intoxication aux acides lévuliniques ?\nQuels tests sont utilisés pour détecter les acides lévuliniques ?\nQuels symptômes indiquent une exposition aux acides lévuliniques ?\nY a-t-il des marqueurs biologiques pour les acides lévuliniques ?\nLes tests d'imagerie sont-ils utiles pour les acides lévuliniques ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Flow+Cytometry&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acides lévuliniques", "description": "Quels sont les symptômes courants d'une exposition ?\nLes acides lévuliniques provoquent-ils des allergies ?\nY a-t-il des effets à long terme d'une exposition ?\nLes symptômes varient-ils selon la dose ?\nLes enfants sont-ils plus sensibles aux acides lévuliniques ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Flow+Cytometry&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acides lévuliniques", "description": "Comment prévenir l'exposition aux acides lévuliniques ?\nLes travailleurs doivent-ils être formés ?\nDes équipements de protection sont-ils nécessaires ?\nY a-t-il des réglementations sur leur utilisation ?\nLes fuites doivent-elles être signalées ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Flow+Cytometry&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acides lévuliniques", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les acides lévuliniques ?\nComment traiter les irritations cutanées causées ?\nLes soins d'urgence sont-ils nécessaires ?\nLa détoxification est-elle recommandée ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Flow+Cytometry&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acides lévuliniques", "description": "Quelles complications peuvent survenir après exposition ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de cancer liés aux acides lévuliniques ?\nLes complications peuvent-elles affecter la santé mentale ?\nDes soins de suivi sont-ils nécessaires après exposition ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Flow+Cytometry&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acides lévuliniques", "description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il la sensibilité ?\nLes personnes allergiques sont-elles plus à risque ?\nY a-t-il des prédispositions génétiques ?\nLes conditions de santé préexistantes augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Flow+Cytometry&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux acides lévuliniques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les acides lévuliniques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux d'acides." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux acides lévuliniques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des nausées, des vertiges et des douleurs abdominales peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les acides lévuliniques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de marqueurs biologiques spécifiques pour ces acides." } }, { "@type": "Question", "name": "Les tests d'imagerie sont-ils utiles pour les acides lévuliniques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'imagerie ne sont généralement pas utilisés pour diagnostiquer l'exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées." } }, { "@type": "Question", "name": "Les acides lévuliniques provoquent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques à ces acides." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme d'une exposition ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des problèmes respiratoires et cutanés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Les enfants sont-ils plus sensibles aux acides lévuliniques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques de ces acides." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux acides lévuliniques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des acides lévuliniques et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle pour les travailleurs." } }, { "@type": "Question", "name": "Des équipements de protection sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des gants et des masques doivent être portés lors de la manipulation de ces acides." } }, { "@type": "Question", "name": "Y a-t-il des réglementations sur leur utilisation ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent l'utilisation des acides lévuliniques dans l'industrie." } }, { "@type": "Question", "name": "Les fuites doivent-elles être signalées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, toute fuite ou déversement doit être signalé immédiatement aux autorités compétentes." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement à éliminer l'exposition et à gérer les symptômes." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les acides lévuliniques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour l'intoxication aux acides lévuliniques." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des soins d'urgence peuvent être nécessaires en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "La détoxification est-elle recommandée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La détoxification n'est généralement pas nécessaire, mais une surveillance médicale est conseillée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles respiratoires ou des dermatites peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des complications sont réversibles avec un traitement approprié et rapide." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés aux acides lévuliniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de preuves concluantes liant ces acides à un risque accru de cancer." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la santé mentale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications physiques peuvent entraîner des effets sur la santé mentale, comme l'anxiété." } }, { "@type": "Question", "name": "Des soins de suivi sont-ils nécessaires après exposition ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical est recommandé pour surveiller d'éventuelles complications tardives." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique sont les plus à risque d'exposition aux acides." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "Les personnes allergiques sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus sensibles aux acides." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines prédispositions génétiques peuvent influencer la sensibilité aux toxines." } }, { "@type": "Question", "name": "Les conditions de santé préexistantes augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme l'asthme ou des maladies cutanées peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Ophthalmic artery flow direction change predicts recurrence of ischemic stroke after carotid stenting: a longitudinal observational study.

The implantation of carotid artery stents prevents recurrent ischemic stroke in patients with carotid stenosis. This study aimed to investigate associations between change of ophthalmic artery flow (C... This retrospective, longitudinal cohort study recruited 87 left side carotid stenosed ischemic stroke patients undergoing left side carotid stenting between year of 2009 and 2013, and patients were fo... Among 87 included patients undergone left side carotid stent treatment, 44 had stroke recurrence within 3 years after carotid stenting. The recurrence group had significantly greater proportions of CO... Prognosis after carotid stenting is poorer for patients with MCA stenosis > 50%, BA/VA stenosis > 50% and/or COAF. Carotid duplex and magnetic resonance angiography provide definitive information for ...

Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study.

High-flow nasal therapy (HFNT) provides several pathophysiological benefits in chronic respiratory disorders. We aimed to evaluate the effectiveness of long-term HFNT in patients with bronchiectasis (... This is a retrospective bicentric case-control study of outpatients with BE on optimized medical treatment with a severe exacerbation requiring hospitalization in the previous year. Patients on long-t... 20 patients in the HFNT group and 20 controls were included. A significant reduction in exacerbations [-1.9 (-2.8 to -0.9),... In this preliminary study, long-term domiciliary HFNT improved the clinical course of patients with BE....

Lateralization of cerebral blood flow in the auditory cortex of patients with idiopathic tinnitus and healthy controls: An arterial spin labeling study.

To assess the lateralization of cerebral blood flow (CBF) in the auditory cortex of idiopathic tinnitus patients and healthy controls (HCs) using 3D pseudocontinuous arterial spin labeling (pcASL).... Thirty-six patients with idiopathic tinnitus and 43 sex- and age-matched HCs underwent 3D-pcASL scanning using a 3.0 T MRI system. For both groups, region of interest analysis was performed on the pri... In both tinnitus patients and HCs, CBF of the left PAC was significantly higher than that of the right (HCs:... This study confirms the asymmetry of the auditory cortex and investigates the underlying neuropathology of idiopathic tinnitus in terms of CBF....

Benefits of the selective invasive strategy guided by CTA and CTA-derived fractional flow reserve in patients with coronary artery disease.

Coronary computed tomography angiography (CTA) has high diagnostic accuracy in ruling out significant stenosis of coronary arteries. The additional use of CTA- derived fractional flow reserve (FFR) fu... We analyzed the impact of a "diseased-vessel-only" selective invasive diagnostic approach in 100 patients undergoing ICA following coronary CTA (and CT-FFR) as compared to the traditional "full ICA" a... Sensitivity, specificity, positive predictive value, and negative predictive value of CTA in prediction of subsequent revascularization were 96%, 75%, 51%, and 99%, respectively, and for CT-FFR 90%, 9... These real-world data support the concept that vessels with <50% diameter stenosis on quantitative computed tomography and with hemodynamically insignificant CTA-derived FFR result may be omitted duri...

Experimental study of DNAPL displacement by a new densified polymer solution and upscaling problems of aqueous polymer flow in porous media.

The remediation of DNAPL-contaminated soil with lower-density fluids is ineffective due to the over-riding of displacing fluid. The densification of biopolymers is experimentally studied to develop a ...